277 related articles for article (PubMed ID: 28459416)
21. Common variation in ZNF804A (rs1344706) is not associated with brain morphometry in schizophrenia or healthy participants.
Quidé Y; Matosin N; Atkins JR; Fitzsimmons C; Cairns MJ; Carr VJ; ; Green MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():12-20. PubMed ID: 29247760
[TBL] [Abstract][Full Text] [Related]
22. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
[TBL] [Abstract][Full Text] [Related]
23. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.
Chung Y; Haut KM; He G; van Erp TGM; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; Cannon TD;
Schizophr Res; 2017 Nov; 189():169-174. PubMed ID: 28245961
[TBL] [Abstract][Full Text] [Related]
24. No regional gray matter volume reduction observed in young Japanese people at ultra-high risk for psychosis: A voxel-based morphometry study.
Sakuma A; Obara C; Katsura M; Ito F; Ohmuro N; Iizuka K; Kikuchi T; Miyakoshi T; Matsuoka H; Matsumoto K
Asian J Psychiatr; 2018 Oct; 37():167-171. PubMed ID: 30293050
[TBL] [Abstract][Full Text] [Related]
25. Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise study.
Tordesillas-Gutierrez D; Koutsouleris N; Roiz-Santiañez R; Meisenzahl E; Ayesa-Arriola R; Marco de Lucas E; Soriano-Mas C; Suarez-Pinilla P; Crespo-Facorro B
Schizophr Res; 2015 May; 164(1-3):74-82. PubMed ID: 25687531
[TBL] [Abstract][Full Text] [Related]
26. Impairment of perceptual metacognitive accuracy and reduced prefrontal grey matter volume in first-episode psychosis.
Davies G; Rae CL; Garfinkel SN; Seth AK; Medford N; Critchley HD; Greenwood K
Cogn Neuropsychiatry; 2018 May; 23(3):165-179. PubMed ID: 29485348
[TBL] [Abstract][Full Text] [Related]
27. Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.
Klauser P; Zhou J; Lim JK; Poh JS; Zheng H; Tng HY; Krishnan R; Lee J; Keefe RS; Adcock RA; Wood SJ; Fornito A; Chee MW
Schizophr Bull; 2015 Nov; 41(6):1285-93. PubMed ID: 25745033
[TBL] [Abstract][Full Text] [Related]
28. Relationship between grey matter integrity and executive abilities in aging.
Manard M; Bahri MA; Salmon E; Collette F
Brain Res; 2016 Jul; 1642():562-580. PubMed ID: 27107940
[TBL] [Abstract][Full Text] [Related]
29. Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis.
Harrisberger F; Smieskova R; Vogler C; Egli T; Schmidt A; Lenz C; Simon AE; Riecher-Rössler A; Papassotiropoulos A; Borgwardt S
Transl Psychiatry; 2016 Aug; 6(8):e868. PubMed ID: 27505231
[TBL] [Abstract][Full Text] [Related]
30. Gray matter differences between affective and non-affective first episode psychosis: A review of Magnetic Resonance Imaging studies: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
Calvo A; Delvecchio G; Altamura AC; Soares JC; Brambilla P
J Affect Disord; 2019 Jan; 243():564-574. PubMed ID: 29625792
[TBL] [Abstract][Full Text] [Related]
31. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
32. Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness.
Bergé D; Mané A; Lesh TA; Bioque M; Barcones F; Gonzalez-Pinto AM; Parellada M; Vieta E; Castro-Fornieles J; Rodriguez-Jimenez R; García-Portilla MP; Usall J; Carter CS; Cabrera B; Bernardo M; Janssen J;
Schizophr Bull; 2020 Jul; 46(4):846-856. PubMed ID: 31915835
[TBL] [Abstract][Full Text] [Related]
33. Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis.
Palaniyappan L; Maayan N; Bergman H; Davenport C; Adams CE; Soares-Weiser K
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011021. PubMed ID: 26252640
[TBL] [Abstract][Full Text] [Related]
34. Individualized covariance profile of cortical morphology for auditory hallucinations in first-episode psychosis.
Yun JY; Kim SN; Lee TY; Chon MW; Kwon JS
Hum Brain Mapp; 2016 Mar; 37(3):1051-65. PubMed ID: 26678706
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
[TBL] [Abstract][Full Text] [Related]
36. Cingulate volume abnormalities in emerging psychosis.
Röthlisberger M; Riecher-Rössler A; Aston J; Fusar-Poli P; Radü EW; Borgwardt S
Curr Pharm Des; 2012; 18(4):495-504. PubMed ID: 22239580
[TBL] [Abstract][Full Text] [Related]
37. Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes.
Koutsouleris N; Schmitt GJ; Gaser C; Bottlender R; Scheuerecker J; McGuire P; Burgermeister B; Born C; Reiser M; Möller HJ; Meisenzahl EM
Br J Psychiatry; 2009 Sep; 195(3):218-26. PubMed ID: 19721111
[TBL] [Abstract][Full Text] [Related]
38. Grey matter, an endophenotype for schizophrenia? A voxel-based morphometry study in siblings of patients with schizophrenia.
van der Velde J; Gromann PM; Swart M; de Haan L; Wiersma D; Bruggeman R; Krabbendam L; Aleman A
J Psychiatry Neurosci; 2015 May; 40(3):207-13. PubMed ID: 25768029
[TBL] [Abstract][Full Text] [Related]
39. Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study.
Buehlmann E; Berger GE; Aston J; Gschwandtner U; Pflueger MO; Borgwardt SJ; Radue EW; Riecher-Rössler A
J Psychiatr Res; 2010 May; 44(7):447-53. PubMed ID: 19939408
[TBL] [Abstract][Full Text] [Related]
40. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
